Курс акций ACLARA BioSciences [ISIN: US00461P1066]

Aclara Biosciences develops lab-on-a-chip technologies for use in genomics research and pharmaceutical drug screening. ACLARA Biosciences provides assay chemistry solutions for drug discovery and development, providing critical high-value information about the expression and interaction of genes and proteins within cells. ACLARA is dedicated to unlocking the power of pathway biology to identify highly specific protein-based biomarkers, accelerate the development of next-generation targeted therapeutics, and recognize the most appropriate patients for approved therapies, thereby enabling physicians to create personalized treatment regimens for patients suffering from cancer and other life-threatening diseases. Aclara Biosciences Inc. was founded in 1995 and is based in Mountain View, California. As of December 10, 2004, Aclara Biosciences Inc. was acquired by Monogram Incorporated.